Skip to main content
. 2020 Jun 16;13(9):1210–1223. doi: 10.1016/j.jiph.2020.06.016

Table 2.

In silico inhibition constant (Ki) obtained by molecular docking for the top 10 drugs.

S. no. Ligands In silico inhibition constant in (Ki) value in Molar
1. Lopinavir–Ritonavir 1.6754 × 10−8
2. Tipranavir 4.1487 × 10−7
3. Raltegravir 8.1265 × 10−7
4. Improved-α-ketoamide 13b 8.1535 × 10−7
5. Nelfinavir 9.6539 × 10−7
6. Dolutegravir 1.1230 × 10−6
7. Tenofovir-disoproxil 1.1430 × 10−6
8. Baloxavir-marboxil 1.1435 × 10−6
9. Letermovir 1.3533 × 10−6
10. Maraviroc 1.3236 × 10−6